Controlled Release Veterinary Drug Delivery

Controlled Release Veterinary Drug Delivery

4.11 - 1251 ratings - Source

Many controlled release veterinary drug delivery systems (CRVDDS) are presently in use, and recently there has been a host of new CRVDDS within veterinary medicine. The challenges of this area of drug delivery arise from the unique anatomy and physiology of the target animal, the cost constraints associated with the value of the animal being treated and the extended periods of time that delivery must be sustained for (often measured in months). The purpose of this book is to introduce the reader to the unique opportunities and challenges of the field of CRVDDS and to explain and discuss the basic controlled release principles underlying the development of CRVDDS. Its aim is to provide an overview of many of the areas where CRVVDS have application, and to highlight the opportunities and prospects for controlled release technology in the veterinary field. Controlled Release Veterinary Drug Delivery comprises chapters that provide workers in the field (and those interested in this area) with information on the design, development and assessment of a variety of CRVDDS. The book contains chapters that describe the relevant animal physiological and anatomical considerations alongside descriptions of current and emerging controlled release delivery systems for a variety of routes for drug delivery, and present overviews on the physical and chemical assessment of veterinary controlled release delivery systems. The veterinary area is abound with opportunities for the development of controlled release drug delivery technologies. It is an area of medicine that is open to the acceptance of novel drug delivery devices, and which readily encompasses the use of novel routes of administration. It is an area of many unmet needs, most of which offer opportunities and unique challenges for the innovative formulation scientist to provide solutions. This book will provide an insight into the biological, clinical and pharmaceutical challenges that face the formulation scientist in this interesting and diverse area of research.Table 1 (continued) Organization Specific documents of interest Website address International Home page ... Access to ICH topics and guidelines http://www.ifpma. org/ich5.html Associations ICH Hannonized Tripartite Guideline: stability Access ... Accelerated stability studies should be conducted on the developmental formulation(s) at 40AdC/75% RH for up to 6 months. The purpose of such studies would be to compare the effect of formulation components, packaging materials and/oranbsp;...

Title:Controlled Release Veterinary Drug Delivery
Author:M.J. Rathbone, R. Gurny
Publisher:Elsevier - 2000-07-20


You Must CONTINUE and create a free account to access unlimited downloads & streaming